Clinical trial
Antidepressant Medication Plus Donepezil for Treating Late-life Depression
NCT00177671 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00177671 |
|---|---|
| Title | Antidepressant Medication Plus Donepezil for Treating Late-life Depression |
| Official title | Maintenance Therapies in Late-Life Depression: MTLD III |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression, Dementia |
| Intervention type | Drug |
| Interventions | Escitalopram, Donepezil, Venlafaxine, Placebo, Duloxetine |
| Enrollment | 220 |
| Start date | Dec 1, 2003 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: